Jin‐Ju Byeon

419 total citations
26 papers, 333 citations indexed

About

Jin‐Ju Byeon is a scholar working on Molecular Biology, Oncology and Pharmaceutical Science. According to data from OpenAlex, Jin‐Ju Byeon has authored 26 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Pharmaceutical Science. Recurrent topics in Jin‐Ju Byeon's work include Drug Solubulity and Delivery Systems (5 papers), Receptor Mechanisms and Signaling (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Jin‐Ju Byeon is often cited by papers focused on Drug Solubulity and Delivery Systems (5 papers), Receptor Mechanisms and Signaling (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Jin‐Ju Byeon collaborates with scholars based in South Korea. Jin‐Ju Byeon's co-authors include Young‐Guk Na, Cheong‐Weon Cho, Hong-Ki Lee, Min‐Ki Kim, Young G. Shin, Min-Gu Han, Hyun Wook Huh, Min‐Ho Park, Yuri Park and Miao Wang and has published in prestigious journals such as Molecules, Acta Biomaterialia and International Journal of Pharmaceutics.

In The Last Decade

Jin‐Ju Byeon

25 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jin‐Ju Byeon South Korea 10 141 86 64 47 43 26 333
Katsumi Iga Japan 13 120 0.9× 128 1.5× 49 0.8× 23 0.5× 20 0.5× 42 464
Hossein M. Elbadawy Saudi Arabia 13 58 0.4× 148 1.7× 45 0.7× 24 0.5× 114 2.7× 50 570
Krishna Sanka India 10 234 1.7× 65 0.8× 18 0.3× 54 1.1× 34 0.8× 28 394
Bianca Sylvester Romania 10 126 0.9× 183 2.1× 31 0.5× 28 0.6× 12 0.3× 11 455
Chin-Mu Hsu Taiwan 16 43 0.3× 163 1.9× 44 0.7× 29 0.6× 10 0.2× 21 478
Emi Kamiyama Japan 11 71 0.5× 85 1.0× 295 4.6× 12 0.3× 51 1.2× 22 476
John Garner United States 8 118 0.8× 80 0.9× 34 0.5× 11 0.2× 13 0.3× 10 354
Carl Roos Sweden 10 232 1.6× 88 1.0× 182 2.8× 36 0.8× 9 0.2× 13 423
Lakshmi Kumari India 7 73 0.5× 84 1.0× 18 0.3× 12 0.3× 5 0.1× 21 297
Chengwu Shen China 11 46 0.3× 179 2.1× 70 1.1× 7 0.1× 7 0.2× 28 421

Countries citing papers authored by Jin‐Ju Byeon

Since Specialization
Citations

This map shows the geographic impact of Jin‐Ju Byeon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin‐Ju Byeon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin‐Ju Byeon more than expected).

Fields of papers citing papers by Jin‐Ju Byeon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin‐Ju Byeon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin‐Ju Byeon. The network helps show where Jin‐Ju Byeon may publish in the future.

Co-authorship network of co-authors of Jin‐Ju Byeon

This figure shows the co-authorship network connecting the top 25 collaborators of Jin‐Ju Byeon. A scholar is included among the top collaborators of Jin‐Ju Byeon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin‐Ju Byeon. Jin‐Ju Byeon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Na, Young‐Guk, Jin‐Ju Byeon, Min‐Ki Kim, et al.. (2020). Development and evaluation of TPGS/PVA-based nanosuspension for enhancing dissolution and oral bioavailability of ticagrelor. International Journal of Pharmaceutics. 581. 119287–119287. 42 indexed citations
4.
Na, Young‐Guk, Jin‐Ju Byeon, Min‐Ki Kim, et al.. (2020). Pharmacokinetic/Pharmacodynamic Modeling To Predict the Antiplatelet Effect of the Ticagrelor-Loaded Self-Microemulsifying Drug Delivery System in Rats. Molecular Pharmaceutics. 17(4). 1079–1089. 6 indexed citations
5.
6.
Park, Yuri, Min‐Ho Park, Jin‐Ju Byeon, et al.. (2020). Assessment of Pharmacokinetics and Metabolism Profiles of SCH 58261 in Rats Using Liquid Chromatography–Mass Spectrometric Method. Molecules. 25(9). 2209–2209. 2 indexed citations
7.
Na, Young‐Guk, Hyun Wook Huh, Min‐Ki Kim, et al.. (2019). Development and evaluation of a film-forming system hybridized with econazole-loaded nanostructured lipid carriers for enhanced antifungal activity against dermatophytes. Acta Biomaterialia. 101. 507–518. 39 indexed citations
8.
Na, Young‐Guk, Jin‐Ju Byeon, Hyun Wook Huh, et al.. (2019). Effect of Ticagrelor, a Cytochrome P450 3A4 Inhibitor, on the Pharmacokinetics of Tadalafil in Rats. Pharmaceutics. 11(7). 354–354. 4 indexed citations
9.
Na, Young‐Guk, Hyun Wook Huh, Miao Wang, et al.. (2019). Systemic Design and Evaluation of Ticagrelor-Loaded Nanostructured Lipid Carriers for Enhancing Bioavailability and Antiplatelet Activity. Pharmaceutics. 11(5). 222–222. 42 indexed citations
10.
Na, Young‐Guk, et al.. (2019). Application of statistical design on the early development of sustained-release tablet containing ivy leaf extract. Journal of Drug Delivery Science and Technology. 54. 101319–101319. 9 indexed citations
11.
Na, Young‐Guk, Jin‐Ju Byeon, Miao Wang, et al.. (2019). Statistical approach for solidifying ticagrelor loaded self-microemulsifying drug delivery system with enhanced dissolution and oral bioavailability. Materials Science and Engineering C. 104. 109980–109980. 20 indexed citations
13.
Na, Young‐Guk, Jin‐Ju Byeon, Miao Wang, et al.. (2019). <p>Strategic approach to developing a self-microemulsifying drug delivery system to enhance antiplatelet activity and bioavailability of ticagrelor</p>. International Journal of Nanomedicine. Volume 14. 1193–1212. 43 indexed citations
15.
Park, Min‐Ho, et al.. (2018). Market Trends of antibody-drug conjugate and its new platform technologies. Yakhak Hoeji. 62(3). 158–170. 1 indexed citations
17.
19.
Park, Min‐Ho, et al.. (2017). Prediction of pharmacokinetics and drug-drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach: A case study of caffeine and ciprofloxacin. Korean Journal of Physiology and Pharmacology. 21(1). 107–107. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026